
Grifols, S.A. GRFS
$ 8.01
0.0%
Quarterly report 2024-Q4
added 05-07-2026
Grifols, S.A. DIO Ratio 2011-2026 | GRFS
Annual DIO Ratio Grifols, S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 0.000171 | 261 | 263 | 275 | 282 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 282 | 0.000171 | 216 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
1.91 K | - | 1.35 % | $ 17.8 M | ||
|
Coherus BioSciences
CHRS
|
97.5 | $ 1.64 | 1.86 % | $ 192 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.12 | -0.32 % | $ 649 M | ||
|
Eton Pharmaceuticals
ETON
|
150 | $ 31.29 | -3.99 % | $ 842 M | ||
|
Affimed N.V.
AFMD
|
69.8 | - | -34.95 % | $ 21.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Heron Therapeutics
HRTX
|
644 | $ 0.88 | 2.85 % | $ 147 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
185 | - | -4.36 % | $ 27 M | ||
|
Anika Therapeutics
ANIK
|
159 | $ 14.89 | 0.07 % | $ 214 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M |